Amylase For Heartburn Scientific Study 2026

---

Table of Contents

1. What Is Amylase and Why Does It Matter for Digestion?
2. The Amylase-Heartburn Connection: How It Works
3. What the 2024–2026 Scientific Studies Actually Say
4. Harvard Health's Position: "Little Evidence" — What This Means
5. Amylase vs. Other Digestive Enzymes for Heartburn Relief
6. Natural Sources of Amylase for Heartburn
7. Amylase Tea for Heartburn: Fact or Folk Remedy?
8. Amylase Dosage for Heartburn: What Studies Suggest
9. How to Choose the Best Amylase Supplement for Heartburn
10. When Elevated Amylase Is a Warning Sign, Not a Treatment
11. Frequently Asked Questions
12. The Bottom Line: Is Amylase Worth Trying for Heartburn?

---

What Is Amylase and Why Does It Matter for Digestion?

If you have ever searched for natural solutions to the burning, uncomfortable sensation of heartburn, you have probably come across digestive enzyme supplements — and amylase is almost always listed near the top of the ingredients panel. But what exactly is amylase, and does the science actually support using it for heartburn relief?

Amylase is a digestive enzyme produced primarily in two locations in your body: the salivary glands (salivary alpha-amylase) and the pancreas (pancreatic amylase). Its main biological job is to break down complex carbohydrates — starches, glycogen, and polysaccharides — into simpler sugars like maltose and glucose so your small intestine can absorb them efficiently.

When you chew a piece of bread, salivary amylase immediately begins dismantling the starch molecules before the food even reaches your stomach. Pancreatic amylase then continues this breakdown in the small intestine. This enzyme is not primarily designed to neutralize stomach acid or prevent reflux — and that distinction matters enormously when evaluating the question of amylase heartburn relief.

Despite this, the supplement industry has heavily marketed enzyme blends containing amylase as digestive aids for people who experience frequent heartburn, bloating, and acid-related discomfort. To assess whether this marketing holds up to scientific scrutiny, we need to look carefully at what the current peer-reviewed evidence actually shows — including the most recent studies published between 2024 and 2026.

---

---

The Amylase-Heartburn Connection: How It Works (Theoretically)

Before examining the evidence, it helps to understand the theoretical mechanism behind amylase and heartburn relief. Proponents of using amylase as a digestive support tool for heartburn typically point to several proposed pathways:

1. Carbohydrate Malabsorption Theory

One of the more scientifically plausible arguments is rooted in carbohydrate malabsorption. When complex carbohydrates are not broken down adequately in the small intestine, they pass into the colon where gut bacteria ferment them. This fermentation process produces gas, which increases intraabdominal pressure. Elevated intraabdominal pressure can, in turn, push stomach contents — including acid — upward through the lower esophageal sphincter (LES), triggering acid reflux and the burning sensation we recognize as heartburn.

If amylase were to improve carbohydrate digestion efficiency, the argument goes, less undigested starch would reach the colon, gas production would decrease, intraabdominal pressure would normalize, and reflux episodes might become less frequent. On paper, this mechanism is logical. In clinical practice, however, the evidence base remains thin.

2. Gastric Emptying Support

A second theoretical argument is that improved upper-digestive enzyme activity might support faster gastric emptying. Delayed gastric emptying (gastroparesis) is a recognized contributor to GERD symptoms because food that sits in the stomach longer creates more opportunity for acid to splash back into the esophagus. However, amylase operates primarily post-stomach in the small intestine, making its direct influence on gastric emptying biologically unclear.

3. Reducing Dietary Starch Load

In some functional medicine circles, heartburn with amylase supplements is discussed in terms of reducing the overall "digestive burden" — the theory being that when the body's enzymatic capacity is supplemented from outside, the stomach does not need to work as hard, acid secretion may be modulated, and reflux becomes less likely. This is largely speculative and has not been tested in well-designed randomized controlled trials specific to amylase as an isolated variable.

Understanding these theoretical frameworks is useful because it explains why people reach for amylase supplements — and why the reality of the clinical evidence is more complicated than the marketing suggests.

---

What the 2024–2026 Scientific Studies Actually Say

This is the core of what you are here for: the actual science. Let's go through the most relevant peer-reviewed data published in the 2024–2026 window and assess what it tells us — honestly and completely.

Study 1: Fermented Soybean Supplementation and Heartburn (2024, MDPI)

One of the most directly relevant 2024 studies examined the effect of fermented soybean (FSB) supplementation on GERD-related symptoms including heartburn. This randomized study, indexed in PubMed and published through MDPI, reported a heartburn subdomain improvement of 47.6% after three months of supplementation. In numerical terms, the intervention group's heartburn scores decreased from 0.420 ± 0.065 to 0.220 ± 0.007 — a statistically significant reduction.

Fermented soybean products are rich in naturally occurring enzymes, including amylase, protease, and other bioactive compounds generated through the fermentation process. The study also reported reductions in inflammatory markers associated with GERD-related mucosal irritation.

What this means for amylase specifically: The results are promising but cannot be attributed solely to amylase activity. Fermented soybean is a complex intervention containing multiple bioactive compounds — isoflavones, probiotics, and several enzyme types — making it impossible to isolate amylase's individual contribution to the observed heartburn improvement. This is a critical distinction that honest analysis requires.

Study 2: Pancreatic Enzymes and Acute Heart Failure (2024, PubMed)

A 2024 study titled "Increase of serum pancreatic enzymes during hospitalization for acute heart failure" found that hospitalized patients with acute heart failure experienced a significant increase in serum pancreatic enzymes — including amylase — within the first 72 hours of admission.

This study is frequently misused in wellness content to imply a connection between amylase and digestive or cardiac health. The actual finding is quite different and in fact represents a caution flag: elevated serum amylase in this context was a marker of systemic physiological stress, not a therapeutic signal. The enzyme elevations reflected organ stress responses, not beneficial enzymatic digestion activity.

What this means for heartburn: This study provides zero evidence supporting amylase supplementation for heartburn. If anything, it reinforces the importance of not conflating serum amylase levels (a clinical diagnostic marker) with the functional role of supplemental amylase in the gut.

Study 3: Serum Amylase and Adverse Outcomes in Acute MI Patients (2025)

A 2025 study titled "Elevated serum amylase concentrations are associated with adverse in-hospital outcomes" examined amylase levels in patients admitted for acute myocardial infarction. The findings linked elevated amylase to worse in-hospital outcomes in cardiac patients.

Again, this is a clinical diagnostic study, not a therapeutic one. It reinforces the broader scientific principle that serum amylase is primarily used as a biomarker for illness severity — particularly pancreatic and now cardiac conditions — rather than as a measurable target for digestive enzyme supplementation therapy.

Study 4: Salivary Alpha-Amylase in Overweight Adults (2024)

A 2024 study titled "Differential expression of cardiometabolic and inflammation markers" examined salivary alpha-amylase activity in overweight and obese adults. While this study confirmed that salivary amylase activity differs in metabolically compromised populations, it was not designed as a heartburn treatment study and does not provide direct evidence for or against amylase heartburn supplement use.

Study 5: Vonoprazan for Non-Erosive Reflux Disease (2023 RCT)

For comparison and scientific context, a rigorous 2023 randomized controlled trial of vonoprazan — a potassium-competitive acid blocker — for non-erosive reflux disease (NERD) found complete and sustained relief in:

• 56.0% of evaluable heartburn episodes at 10 mg
• 60.6% at 20 mg
• 70.0% at 40 mg
• Compared to just 27.3% with placebo

This is relevant because it establishes the benchmark against which enzyme-based interventions would need to compete to be considered clinically meaningful. No comparable randomized controlled trial of amylase supplementation for heartburn exists with these kinds of validated, disease-specific endpoints.

What 2026-Ranked Content Research Confirms

A review of the content currently ranking for this topic as of 2026 confirms that no large-scale, multicenter RCTs of commercial OTC enzyme blends with validated heartburn-specific endpoints have been completed. The evidence gap is real, not a rhetorical device.

---

Harvard Health's Position: "Little Evidence" — What This Means in 2026

Harvard Health's article on digestive enzyme supplements and heartburn has maintained a consistent and evidence-grounded position: there is "little evidence" that over-the-counter digestive enzyme supplements help heartburn. This position, first articulated in detail in 2018, remains cited in 2026-ranked content summaries because the underlying evidence landscape has not dramatically shifted.

It is worth unpacking what "little evidence" means in a scientific context, because this phrase is sometimes misread.

"Little evidence" does not mean:

• That amylase is proven to be ineffective
• That digestive enzymes have no role in gastrointestinal health
• That no studies exist in this space

"Little evidence" does mean:

• That the volume and quality of studies specifically testing amylase supplementation for heartburn endpoints is insufficient to support clinical recommendations
• That the studies that do exist are either too small, too heterogeneous in design, or too confounded by multi-ingredient interventions to isolate amylase's individual effect
• That healthcare providers cannot responsibly recommend amylase supplements as a primary or evidence-backed heartburn treatment based on current data

This is an important scientific distinction. The Harvard position is not dismissive of the supplement category — it is an honest reflection of where the evidence stands. For a condition as common and as impactful as heartburn (affecting an estimated 20% of the Western population weekly), the bar for evidence should be appropriately high.

---

---

Amylase vs. Other Digestive Enzymes for Heartburn Relief

One of the most common questions people ask when exploring amylase benefits heartburn is how amylase compares to other digestive enzymes. Most commercial digestive enzyme blends contain multiple enzymes, and understanding each one's role helps set realistic expectations.

Amylase

Primary role: Breaks down carbohydrates/starches Theoretical heartburn benefit: Reduces fermentable carbohydrate load reaching the colon, potentially decreasing gas and intraabdominal pressure Evidence quality for heartburn: Low — no high-quality RCTs isolating amylase for heartburn endpoints

Protease

Primary role: Breaks down proteins Theoretical heartburn benefit: May reduce protein fermentation in the gut, potentially reducing bloating associated with reflux Evidence quality for heartburn: Low to moderate — some evidence in broader digestive comfort studies

Lipase

Primary role: Breaks down fats Theoretical heartburn benefit: Improved fat digestion may reduce gastric emptying delay, as high-fat meals are a recognized trigger for reflux Evidence quality for heartburn: Low — not well studied in isolation for reflux endpoints

Betaine HCl

Primary role: Provides supplemental hydrochloric acid Theoretical heartburn benefit: Counterintuitively, some functional medicine practitioners argue that low stomach acid (hypochlorhydria) causes reflux, and supplementing acid corrects the underlying cause Evidence quality for heartburn: Controversial — evidence is mixed and this approach is not mainstream medically

Papain and Bromelain (Plant-Based Enzymes)

Primary role: Protein digestion Theoretical heartburn benefit: Similar to protease — may ease protein digestion in the upper GI tract Evidence quality for heartburn: Insufficient high-quality trials

The honest summary: no single digestive enzyme has sufficient RCT-level evidence as a standalone heartburn treatment. Multi-enzyme blends show more promise in some observational studies, but the fermented soybean 2024 data — the strongest recent signal — still does not allow for amylase-specific attribution.

---

Natural Sources of Amylase for Heartburn

Interest in natural amylase heartburn remedies is substantial, and it is worth examining which foods genuinely contain meaningful concentrations of amylase alongside their overall digestive profiles.

Raw Honey

Raw, unprocessed honey contains amylase (specifically diastase), which is introduced during the enzyme activity of honeybees. Raw honey has been traditionally used as a soothing agent for esophageal irritation. While this is primarily a coating and anti-inflammatory effect rather than an enzymatic one in the clinical sense, raw honey's overall digestive gentleness makes it a reasonable supportive food for heartburn sufferers.

Mangoes

Ripe mangoes contain naturally occurring amylase enzymes alongside other digestive-supportive compounds. They are also rich in fiber, which can aid overall gut motility. However, the fructose content in large quantities may trigger symptoms in fructose-sensitive individuals, so moderation is appropriate.

Bananas

Bananas, particularly when slightly overripe, contain amylase as part of the starch-to-sugar conversion process that occurs as the fruit ripens. Bananas are also commonly recommended as a low-acid food appropriate for heartburn sufferers, making them a useful dual-benefit food.

Papaya

Papaya contains papain (a protease) and amylase-adjacent enzymes. It is frequently cited in digestive health circles and is the basis for several commercial digestive enzyme supplements. Some evidence supports papaya's role in reducing bloating and improving digestive comfort, though heartburn-specific RCT evidence is lacking.

Fermented Foods

As the 2024 MDPI fermented soybean study highlighted, fermented foods are rich in naturally occurring enzymes including amylase. Kimchi, miso, tempeh, and kefir all contain enzymatic activity from the fermentation process. These foods also deliver probiotic benefits that may independently support the gut-esophageal axis in GERD management.

The case for natural amylase heartburn approaches is that incorporating enzyme-rich whole foods carries minimal risk, provides multiple nutritional benefits, and aligns with the overall dietary shift toward whole food patterns that is associated with reduced GERD symptoms.

---

Amylase Tea for Heartburn: Fact or Folk Remedy?

The concept of amylase tea heartburn relief occupies an interesting space between traditional herbalism and emerging food science. Several teas have been associated with digestive enzyme activity or digestive comfort in ways that intersect with the amylase conversation.

Ginger Tea

Ginger contains natural digestive enzymes (zingibain, a protease) and has demonstrated anti-nausea and prokinetic properties in clinical research. While ginger is not a primary source of amylase, its prokinetic effect — stimulating gastric motility — addresses one of the mechanical contributors to heartburn. A 2019 review in the journal Food Science & Nutrition found that ginger extract reduced several markers of GERD symptom severity.

Chamomile Tea

Chamomile has anti-inflammatory and antispasmodic properties that may help relax the lower esophageal sphincter area and reduce esophageal irritation. It does not contribute meaningful amylase activity but is a well-tolerated supportive option.

Slippery Elm Tea

Slippery elm contains mucilage — a gel-like substance that coats the esophagus and stomach lining — making it one of the more physiologically plausible herbal heartburn interventions. While it does not deliver amylase, its mechanism of action (mucosal protection) is relevant to heartburn pathophysiology.

The Honest Assessment of Amylase Tea

The scientific reality is that amylase tea as a distinct category — teas specifically designed to deliver functional amylase activity for heartburn relief — is more marketing concept than evidence-based practice. Enzymatic activity in tea preparations is affected by processing temperature (boiling water typically denatures most enzymes), pH, and storage conditions. Any amylase present in raw plant material used to make tea is likely denatured in the brewing process before it reaches your digestive tract.

This does not mean tea is unhelpful for heartburn. Warm liquids, hydration, anti-inflammatory phytochemicals, and prokinetic compounds in various teas may provide real benefit. But attributing that benefit specifically to amylase delivery via tea would be scientifically inaccurate based on current evidence.

---

Amylase Dosage for Heartburn: What Studies Suggest

One of the most frequently searched questions about amylase dosage heartburn involves how much amylase is appropriate in a supplement context. The honest answer is that there is no clinically validated dose established specifically for heartburn relief, because no high-powered RCTs have been conducted with amylase-specific dosing as the primary variable.

However, we can outline what is known:

Standard Dosing in Commercial Products

Most over-the-counter digestive enzyme supplements containing amylase list dosages in DU (Diastatic Units) — a measure of enzyme activity rather than raw weight. Common commercial formulations range from:

• 3,000–5,000 DU per capsule in basic enzyme blends
• 10,000–20,000 DU per capsule in higher-potency formulations

The Enzyme Technical Association (ETA) provides standardized measurement protocols for enzyme activity, and reputable supplement manufacturers should follow these standards.

What Prescription Enzyme Therapy Tells Us

Prescription pancreatic enzyme replacement therapy (PERT) — used for conditions like chronic pancreatitis and exocrine pancreatic insufficiency — delivers amylase in the range of 17,500–25,000 USP units per meal within standardized lipase/protease/amylase blends. These doses are designed to replace lost pancreatic function, which is a fundamentally different clinical goal than supplementing normal digestive function for heartburn relief.

The extrapolation from PERT dosing to OTC heartburn supplementation is scientifically problematic and should not be assumed.

Timing Considerations

Most digestive enzyme supplements are recommended to be taken immediately before or at the beginning of meals, which allows them to mix with food in the stomach and small intestine where they are intended to be active. Taking amylase supplements after a meal reduces their contact time with the food substrate they are meant to digest.

The Safety Profile

At doses found in commercial OTC supplements, amylase is generally considered safe for most individuals. It is a protein, and excess supplemental amylase is itself digested by the body's proteolytic enzymes. However, individuals with known pancreatic conditions, those on prescription medications for GERD, and pregnant or breastfeeding individuals should consult a healthcare provider before starting any enzyme supplement.

---

How to Choose the Best Amylase Supplement for Heartburn

Given that the evidence base is emerging rather than definitive, if you are considering an amylase heartburn supplement, there are evidence-informed criteria that should guide your selection.

Look for Third-Party Testing

The supplement industry in the United States is regulated differently from pharmaceuticals. Without mandatory pre-market approval, product quality varies significantly. Look for products certified by NSF International, USP (United States Pharmacopeia), or Informed Sport — third-party bodies that test for label accuracy, contamination, and potency.

Choose Broad-Spectrum Enzyme Blends

Given that the strongest digestive benefit data comes from multi-enzyme interventions (as in the fermented soybean study and broader research on digestive enzyme blends), a formulation that combines amylase with protease, lipase, and potentially cellulase offers a more comprehensive digestive support profile than amylase alone.

Check for FCC-Compliant Enzyme Activity Labeling

Reputable enzyme supplements list their enzyme potency using FCC (Food Chemicals Codex) units — DU for amylase, LU or FIP for lipase, HUT for protease. Products that list only milligrams of enzyme without activity units provide no useful information about actual potency.

Consider the Delivery Format

Enteric-coated capsules are designed to resist stomach acid and release enzymes in the small intestine, where most digestive activity occurs. For heartburn specifically — which is an esophageal and gastric event — standard (non-enteric-coated) capsules that release earlier in the digestive process may be more appropriate, though this is an area of ongoing formulation debate.

Avoid Exaggerated Claims

Any amylase extract heartburn product that claims to "cure GERD," "eliminate acid reflux permanently," or "replace prescription medication" is making claims that are not supported by current science. Regulatory agencies including the FDA require supplements to include disclaimers that their products are "not intended to diagnose, treat, cure, or prevent any disease."

---

---

When Elevated Amylase Is a Warning Sign, Not a Treatment

This section is critically important and often overlooked in wellness content about amylase benefits heartburn: elevated serum amylase levels in your bloodstream are not a sign that you have more digestive support — they are frequently a sign of serious illness.

Acute Pancreatitis

StatPearls (the clinical reference database maintained by the National Library of Medicine) states clearly that serum amylase levels exceeding three times the upper reference limit strongly suggest acute pancreatitis. Acute pancreatitis presents with severe abdominal pain that can radiate to the back, nausea, vomiting, and fever — symptoms that may superficially overlap with severe GERD in patient-reported descriptions but are a distinct and potentially life-threatening emergency.

If you experience sudden, severe upper abdominal pain with nausea and vomiting and your doctor orders amylase blood tests that return markedly elevated, the clinical concern is pancreatitis — not a sign that you need more enzyme supplements.

Acute Cardiac Events

As noted in the 2024 and 2025 studies discussed earlier, elevated serum amylase has been associated with adverse outcomes in both acute heart failure and acute myocardial infarction. These findings are relevant to patients who may misattribute cardiac symptoms to digestive problems — a known and potentially dangerous pattern, particularly in women, for whom cardiac events frequently present with atypical gastrointestinal symptoms.

What This Means for Self-Diagnosis

If you are experiencing frequent heartburn that is not responding to standard dietary modifications and OTC antacids, do not simply layer on enzyme supplements as a self-treatment strategy. The appropriate step is evaluation by a gastroenterologist who can rule out erosive esophagitis, Barrett's esophagus, hiatal hernia, and other conditions that require specific medical management.

The ASGE published a 2025 guideline specifically on the role of endoscopy in GERD management, underscoring that for moderate to severe or treatment-resistant reflux, clinical evaluation — not supplement self-prescription — is the appropriate pathway.

---

Frequently Asked Questions

Does amylase help with heartburn?

Based on current evidence, there is no high-quality randomized controlled trial demonstrating that amylase supplementation alone produces clinically meaningful heartburn relief. Some multi-enzyme and fermented food interventions show promise (including the 47.6% heartburn improvement in the 2024 fermented soybean study), but these effects cannot be attributed specifically to amylase as an isolated variable. The theoretical mechanisms are plausible — particularly the carbohydrate malabsorption pathway — but plausible mechanisms require rigorous clinical testing before they become clinical recommendations.

Is amylase an effective digestive enzyme for acid reflux or GERD?

Amylase is an effective enzyme for its primary purpose: breaking down dietary starches. Whether this starch-digesting activity translates into meaningful reduction of acid reflux or GERD symptoms in clinical trials is not yet established. Harvard Health's position that there is "little evidence" for OTC digestive enzymes in heartburn management reflects the current state of the literature accurately.

Are digestive enzyme supplements safe for heartburn?

For most otherwise healthy adults, OTC digestive enzyme supplements at labeled doses are generally considered safe. They are contraindicated or require medical supervision in individuals with known pancreatic conditions, active gastrointestinal disease, or those on anticoagulant medications (some enzyme preparations have mild fibrinolytic activity). They should not be used as a replacement for prescribed medications for diagnosed GERD or erosive esophagitis without physician guidance.

What is the difference between amylase and other enzymes like protease or lipase for reflux symptoms?

Amylase targets carbohydrates, protease targets proteins, and lipase targets fats. From a heartburn perspective, each addresses a different dietary component that, when incompletely digested, might contribute to fermentation, gas, and increased intraabdominal pressure. Lipase may be particularly relevant given that high-fat meals are a well-established trigger for reflux episodes. No single enzyme has demonstrated superiority over others in heartburn-specific clinical trials.

Is there any scientific evidence from 2024–2026 supporting enzymes for heartburn relief?

The strongest 2024 evidence comes from the fermented soybean supplementation study, which showed a 47.6% improvement in heartburn subdomains. This is encouraging but methodologically limited for isolating amylase as the active agent. No new large-scale RCTs specifically testing commercial amylase or multi-enzyme supplements with validated heartburn endpoints were identified as completed through 2026. The most robust heartburn treatment trial from this period (vonoprazan, 2023) was a pharmaceutical acid-blocking agent, not an enzyme supplement.

Can I take amylase supplements alongside my GERD medication?

In most cases, taking an OTC amylase-containing digestive enzyme supplement alongside standard acid-suppressing therapy (PPIs, H2 blockers) is unlikely to cause a dangerous interaction. However, because enzyme supplements can affect the rate of digestion and potentially the absorption of some medications, it is always advisable to consult your prescribing physician before combining supplements with prescription drugs.

How long does it take for amylase supplements to work for heartburn?

Because there is no established clinical protocol for amylase dosing in heartburn, there is no evidence-based timeline to offer. In the fermented soybean study, significant heartburn improvement was observed over three months of consistent supplementation. Individual responses in supplement trials typically show gradual change over weeks rather than immediate symptom relief as might be expected from an antacid.

---

The Bottom Line: Is Amylase Worth Trying for Heartburn?

After reviewing the complete landscape of current scientific evidence — including the most recent 2024 and 2025 peer-reviewed studies, the positions of major health institutions, and the state of the clinical trial literature through 2026 — here is where the evidence honestly stands on amylase for heartburn:

What the science supports:

• Amylase is a well-characterized, physiologically important digestive enzyme with a clear mechanistic rationale for potential involvement in reducing one specific pathway of heartburn (carbohydrate fermentation → gas → intraabdominal pressure → reflux)
• Multi-enzyme fermented food interventions show meaningful heartburn benefit in recent randomized research (47.6% improvement in the 2024 FSB study)
• Natural amylase-rich foods (raw honey, fermented foods, ripe tropical fruits) carry minimal risk and plausible digestive benefits as part of an overall anti-reflux dietary pattern
• OTC amylase supplements appear safe for most healthy adults at standard doses

What the science does not yet support:

• Amylase supplementation as a standalone, validated treatment for heartburn or GERD
• Specific clinical dosing recommendations for amylase dosage heartburn management
• Any claim that amylase supplements can replace or rival evidence-based medical therapies (PPIs, H2 blockers, vonoprazan) for GERD management
• The use of elevated serum amylase as a therapeutic target — this is a diagnostic marker for serious illness, not a treatment parameter

The pragmatic recommendation:

If you experience occasional heartburn and are interested in digestive enzyme support as a complementary approach, a high-quality multi-enzyme supplement containing amylase (along with protease and lipase), used alongside proven dietary modifications — smaller meals, reduced fat intake, elevation of the head of the bed, avoidance of trigger foods — is a reasonable low-risk addition to your regimen.

If your heartburn is frequent (more than twice per week), severe, associated with difficulty swallowing, unexplained weight loss, or unresponsive to standard OTC approaches, the appropriate next step is clinical evaluation, not an escalation of supplement dosing.

The best amylase for heartburn is ultimately one component of a broader digestive health strategy — not a silver bullet. The 2026 evidence landscape tells us the conversation is still evolving, the mechanisms are real, the clinical proof is incomplete, and honest expectations are the most useful tool any heartburn sufferer can bring to their health decisions.

---

---

References and Sources

1. Verdant Wellness. Digestive Enzyme Blend for Heartburn: Phytochemistry. verdantwellness.co/blogs/debloat-gut-relief/digestive-enzyme-blend-for-heartburn-phytochemistry
2. StatPearls. Amylase. National Center for Biotechnology Information. ncbi.nlm.nih.gov/books/NBK557738/
3. Harvard Health Publishing. Will Digestive Enzyme Supplements Help Your Heartburn? 2018. health.harvard.edu/blog/will-digestive-enzyme-supplements-help-your-heartburn-2018041313643
4. PubMed 2024. Increase of serum pancreatic enzymes during hospitalization for acute heart failure. PubMed-indexed peer-reviewed study.
5. MDPI 2024. Effect of Fermented Soybean (FSB) Supplementation on Heartburn and GERD-Related Symptoms. Randomized study with 47.6% heartburn subdomain improvement over 3 months.
6. PubMed 2024. Differential expression of cardiometabolic and inflammation markers: salivary alpha-amylase in overweight/obese adults.
7. PubMed 2025. Elevated serum amylase concentrations are associated with adverse in-hospital outcomes in acute MI patients.
8. ASGE 2025. Guideline on the Role of Endoscopy in the Management of GERD.
9. Randomized Trial 2023. Vonoprazan for Non-Erosive Reflux Disease: Complete heartburn relief at 10 mg (56.0%), 20 mg (60.6%), 40 mg (70.0%) vs. placebo (27.3%).

---

This blog post is for educational and informational purposes only. It does not constitute medical advice and is not a substitute for consultation with a qualified healthcare provider. If you are experiencing symptoms of heartburn, acid reflux, or GERD, please consult a gastroenterologist or primary care physician for proper diagnosis and treatment.